Cargando…
Fibrinogen α-Chain as a Serum Marker of Liver Disease
Liver fibrosis is the hepatic response to an insult characterized by an accumulation of extracellular matrix proteins. If the underlying cause is not treated or eliminated, the disease can progress and may lead to several clinical complications including hepatocellular carcinoma or even death. Thus,...
Autores principales: | Marfà, Santiago, Jimenez, Wladimiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123997/ http://dx.doi.org/10.1007/978-94-007-7675-3_7 |
Ejemplares similares
-
Lack of a 5.9 kDa Peptide C-Terminal Fragment of Fibrinogen α Chain Precedes Fibrosis Progression in Patients with Liver Disease
por: Marfà, Santiago, et al.
Publicado: (2014) -
Sipa1l1 is an early biomarker of liver fibrosis in CCl(4)-treated rats
por: Marfà, Santiago, et al.
Publicado: (2016) -
Metastatic Tissue Proteomic Profiling Predicts 5-Year Outcomes in Patients with Colorectal Liver Metastases()
por: Marfà, Santiago, et al.
Publicado: (2016) -
Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage
por: Callea, Francesco, et al.
Publicado: (2017) -
Proteomic Analysis for the Diagnosis of Fibrinogen Aα-chain Amyloidosis
por: Taylor, Graham W., et al.
Publicado: (2019)